TY - JOUR AU - Bolla, M. AU - Maingon, P. AU - Carrie, C. AU - Villa, S. AU - Kitsios, P. AU - Poortmans, P. PY - 2016 DA - 2016// TI - Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate Cancer: results of EORTC trial 22991 JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.64.8055 DO - 10.1200/JCO.2015.64.8055 ID - Bolla2016 ER - TY - JOUR AU - James, N. D. AU - Bono, J. S. AU - Spears, M. R. AU - Clarke, N. W. AU - Mason, M. D. AU - Dearnaley, D. P. PY - 2017 DA - 2017// TI - Abiraterone for prostate Cancer not previously treated with hormone therapy JO - N Engl J Med VL - 337 UR - https://doi.org/10.1056/NEJMoa1702900 DO - 10.1056/NEJMoa1702900 ID - James2017 ER - TY - JOUR AU - James, N. D. AU - Sydes, M. R. AU - Clarke, N. W. AU - Mason, M. D. AU - Dearnaley, D. P. AU - Spears, M. R. PY - 2016 DA - 2016// TI - Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01037-5 DO - 10.1016/S0140-6736(15)01037-5 ID - James2016 ER - TY - JOUR AU - Fehm, T. AU - Sagalowsky, A. AU - Clifford, E. AU - Beitsch, P. AU - Saboorian, H. AU - Euhus, D. PY - 2002 DA - 2002// TI - Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant JO - Clin Cancer Res VL - 8 ID - Fehm2002 ER - TY - JOUR AU - Danila, D. C. AU - Heller, G. AU - Gignac, G. A. AU - Gonzalez-Espinoza, R. AU - Anand, A. AU - Tanaka, E. PY - 2007 DA - 2007// TI - Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-1506 DO - 10.1158/1078-0432.CCR-07-1506 ID - Danila2007 ER - TY - JOUR AU - Bono, J. S. AU - Scher, H. I. AU - Montgomery, R. B. AU - Parker, C. AU - Miller, M. C. AU - Tissing, H. PY - 2008 DA - 2008// TI - Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0872 DO - 10.1158/1078-0432.CCR-08-0872 ID - Bono2008 ER - TY - JOUR AU - Olmos, D. AU - Arkenau, H. AU - Ang, J. E. AU - Ledaki, I. AU - Attard, G. AU - Carden, C. P. PY - 2009 DA - 2009// TI - Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-Centre experience JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn544 DO - 10.1093/annonc/mdn544 ID - Olmos2009 ER - TY - JOUR AU - Scher, H. I. AU - Jia, X. AU - Bono, J. S. AU - Fleisher, M. AU - Pienta, K. J. AU - Raghavan, D. PY - 2009 DA - 2009// TI - Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70340-1 DO - 10.1016/S1470-2045(08)70340-1 ID - Scher2009 ER - TY - JOUR AU - Heller, G. AU - McCormack, R. AU - Kheoh, T. AU - Molina, A. AU - Smith, M. R. AU - Dreicer, R. PY - 2018 DA - 2018// TI - Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate Cancer: a comparison with prostate-specific antigen across five randomized phase III clinical trials JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.75.2998 DO - 10.1200/JCO.2017.75.2998 ID - Heller2018 ER - TY - JOUR AU - Lorente, D. AU - Olmos, D. AU - Mateo, J. AU - Bianchini, D. AU - Seed, G. AU - Fleisher, M. PY - 2016 DA - 2016// TI - Decline in circulating tumor cell count and treatment outcome in advanced prostate Cancer JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.05.023 DO - 10.1016/j.eururo.2016.05.023 ID - Lorente2016 ER - TY - JOUR AU - Chalfin, H. J. AU - Glavaris, S. A. AU - Malihi, P. D. AU - Sperger, J. M. AU - Gorin, M. A. AU - Lu, C. PY - 2018 DA - 2018// TI - Prostate Cancer disseminated tumor cells are rarely detected in the bone marrow of patients with localized disease undergoing radical prostatectomy across multiple rare cell detection platforms JO - J Urol VL - 199 UR - https://doi.org/10.1016/j.juro.2018.01.033 DO - 10.1016/j.juro.2018.01.033 ID - Chalfin2018 ER - TY - STD TI - Tsumura H, Satoh T, Ishiyama H, Tabata K, Takenaka K, Sekiguchi A, et al. Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. Int J Mol Sci. 2017;18(1). ID - ref12 ER - TY - JOUR AU - Davis, J. W. AU - Nakanishi, H. AU - Kumar, V. S. AU - Bhadkamkar, V. A. AU - McCormack, R. AU - Fritsche, H. A. PY - 2008 DA - 2008// TI - Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer JO - J Urol VL - 179 UR - https://doi.org/10.1016/j.juro.2008.01.102 DO - 10.1016/j.juro.2008.01.102 ID - Davis2008 ER - TY - JOUR AU - Thalgott, M. AU - Rack, B. AU - Horn, T. AU - Heck, M. M. AU - Eiber, M. AU - Kübler, H. PY - 2015 DA - 2015// TI - Detection of circulating tumor cells in locally advanced high-risk prostate Cancer during Neoadjuvant chemotherapy and radical prostatectomy JO - Anticancer Res VL - 35 ID - Thalgott2015 ER - TY - JOUR AU - Loh, J. AU - Jovanovic, L. AU - Lehman, M. AU - Capp, A. AU - Pryor, D. AU - Harris, M. PY - 2014 DA - 2014// TI - Circulating tumor cell detection in high-risk non-metastatic prostate cancer JO - J Cancer Res Clin Oncol VL - 140 UR - https://doi.org/10.1007/s00432-014-1775-3 DO - 10.1007/s00432-014-1775-3 ID - Loh2014 ER - TY - JOUR AU - Gewanter, R. M. AU - Katz, A. E. AU - Olsson, C. A. AU - Benson, M. C. AU - Singh, A. AU - Schiff, P. B. PY - 2003 DA - 2003// TI - RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy JO - Urology VL - 61 UR - https://doi.org/10.1016/S0090-4295(02)02581-5 DO - 10.1016/S0090-4295(02)02581-5 ID - Gewanter2003 ER - TY - JOUR AU - Panteleakou, Z. AU - Lembessis, P. AU - Sourla, A. AU - Pissimissis, N. AU - Polyzos, A. AU - Deliveliotis, C. PY - 2009 DA - 2009// TI - Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance JO - Mol Med VL - 15 UR - https://doi.org/10.2119/molmed.2008.00116 DO - 10.2119/molmed.2008.00116 ID - Panteleakou2009 ER - TY - JOUR AU - Miyamoto, D. T. AU - Lee, R. J. PY - 2016 DA - 2016// TI - Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: tools for real-time precision medicine? JO - Urol Oncol VL - 34 UR - https://doi.org/10.1016/j.urolonc.2016.09.001 DO - 10.1016/j.urolonc.2016.09.001 ID - Miyamoto2016 ER - TY - JOUR AU - Gorin, M. A. AU - Verdone, J. E. AU - Toom, E. AU - Bivalacqua, T. J. AU - Allaf, M. E. AU - Pienta, K. J. PY - 2017 DA - 2017// TI - Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer JO - Nat Rev Urol VL - 14 UR - https://doi.org/10.1038/nrurol.2016.224 DO - 10.1038/nrurol.2016.224 ID - Gorin2017 ER - TY - JOUR AU - Goldkorn, A. AU - Ely, B. AU - Quinn, D. I. AU - Tangen, C. M. AU - Fink, L. M. AU - Xu, T. PY - 2014 DA - 2014// TI - Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.51.7417 DO - 10.1200/JCO.2013.51.7417 ID - Goldkorn2014 ER - TY - JOUR AU - Zheng, Y. AU - Zhang, C. AU - Wu, J. AU - Cheng, G. AU - Yang, H. AU - Hua, L. PY - 2016 DA - 2016// TI - Prognostic value of circulating tumor cells in castration resistant prostate Cancer: a meta-analysis JO - Urol J VL - 13 ID - Zheng2016 ER - TY - JOUR AU - Schneck, H. AU - Gierke, B. AU - Uppenkamp, F. AU - Behrens, B. AU - Niederacher, D. AU - Stoecklein, N. H. PY - 2015 DA - 2015// TI - EpCAM-independent enrichment of circulating tumor cells in metastatic breast Cancer JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0144535 DO - 10.1371/journal.pone.0144535 ID - Schneck2015 ER - TY - JOUR AU - Theil, G. AU - Fischer, K. AU - Weber, E. AU - Medek, R. AU - Hoda, R. AU - Lücke, K. PY - 2016 DA - 2016// TI - The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158354 DO - 10.1371/journal.pone.0158354 ID - Theil2016 ER - TY - JOUR AU - Kuske, A. AU - Gorges, T. M. AU - Tennstedt, P. AU - Tiebel, A. K. AU - Pompe, R. AU - Preißer, F. PY - 2016 DA - 2016// TI - Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep39736 DO - 10.1038/srep39736 ID - Kuske2016 ER - TY - JOUR AU - Stott, S. L. AU - Lee, R. J. AU - Nagrath, S. AU - Yu, M. AU - Miyamoto, D. T. AU - Ulkus, L. PY - 2010 DA - 2010// TI - Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer JO - Sci Transl Med VL - 2 UR - https://doi.org/10.1126/scitranslmed.3000403 DO - 10.1126/scitranslmed.3000403 ID - Stott2010 ER - TY - JOUR AU - Meyer, C. P. AU - Pantel, K. AU - Tennstedt, P. AU - Stroelin, P. AU - Schlomm, T. AU - Heinzer, H. PY - 2016 DA - 2016// TI - Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer JO - Urol Oncol VL - 34 UR - https://doi.org/10.1016/j.urolonc.2015.12.003 DO - 10.1016/j.urolonc.2015.12.003 ID - Meyer2016 ER - TY - JOUR AU - Pal, S. K. AU - He, M. AU - Wilson, T. AU - Liu, X. AU - Zhang, K. AU - Carmichael, C. PY - 2015 DA - 2015// TI - Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer JO - Clin Genitourin Cancer VL - 13 UR - https://doi.org/10.1016/j.clgc.2014.08.014 DO - 10.1016/j.clgc.2014.08.014 ID - Pal2015 ER - TY - JOUR AU - Friedlander, T. W. AU - Welty, C. AU - Anantharaman, A. AU - Schonhoft, J. D. AU - Jendrisak, A. AU - Lee, J. PY - 2019 DA - 2019// TI - Identification and characterization of circulating tumor cells in men who have undergone prostatectomy for clinically localized, high risk prostate Cancer JO - J Urol VL - 202 UR - https://doi.org/10.1097/JU.0000000000000393 DO - 10.1097/JU.0000000000000393 ID - Friedlander2019 ER -